Copyright Reports & Markets. All rights reserved.

Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Product
      • 1.4.2 EL-001
      • 1.4.3 LASSBio-785
      • 1.4.4 LASSBio-786
      • 1.4.5 Midazolam Hydrochloride
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by End User
      • 1.5.2 General Anesthetic Effect
      • 1.5.3 Insomnia
      • 1.5.4 Hypertension
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size
      • 2.1.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue 2014-2025
      • 2.1.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales 2014-2025
    • 2.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Growth Rate by Regions
      • 2.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Regions
      • 2.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Manufacturers
      • 3.1.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Manufacturers
      • 3.1.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Market Share by Manufacturers
      • 3.1.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Manufacturers
      • 3.2.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Price by Manufacturers
    • 3.4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Manufacturing Base Distribution, Product Types
      • 3.4.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Product
    • 4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Product
    • 4.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Breakdown Data by End User

    6 North America

    • 6.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Countries
      • 6.1.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Countries
      • 6.1.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Product
    • 6.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by End User

    7 Europe

    • 7.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Countries
      • 7.1.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Countries
      • 7.1.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Product
    • 7.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Countries
      • 8.1.1 Asia Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Countries
      • 8.1.2 Asia Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Product
    • 8.3 Asia Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by End User

    9 Central & South America

    • 9.1 Central & South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Countries
      • 9.1.1 Central & South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Countries
      • 9.1.2 Central & South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Product
    • 9.3 Central & South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Countries
      • 10.1.1 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales by Countries
      • 10.1.2 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Product
    • 10.3 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by End User

    11 Company Profiles

    • 11.1 Jiangsu Hengrui Medicine Co Ltd
      • 11.1.1 Jiangsu Hengrui Medicine Co Ltd Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Products Offered
      • 11.1.5 Jiangsu Hengrui Medicine Co Ltd Recent Development
    • 11.2 Jiangsu Nhwa Pharmaceutical Corp Ltd
      • 11.2.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Products Offered
      • 11.2.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Development
    • 11.3 Paion AG
      • 11.3.1 Paion AG Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Products Offered
      • 11.3.5 Paion AG Recent Development
    • 11.4 Pfizer Inc
      • 11.4.1 Pfizer Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Products Offered
      • 11.4.5 Pfizer Inc Recent Development
    • 11.5 Primex Pharmaceuticals Oy
      • 11.5.1 Primex Pharmaceuticals Oy Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Products Offered
      • 11.5.5 Primex Pharmaceuticals Oy Recent Development
    • 11.6 Shire Plc
      • 11.6.1 Shire Plc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Shire Plc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Shire Plc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Products Offered
      • 11.6.5 Shire Plc Recent Development

    12 Future Forecast

    • 12.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by Regions
      • 12.1.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Forecast by Regions 2019-2025
    • 12.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by Product
      • 12.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Forecast by Product 2019-2025
    • 12.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Forecast by End User
    • 12.4 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Forecast
    • 12.5 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Forecast
    • 12.6 Asia Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Forecast
    • 12.7 Central & South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Forecast
    • 12.8 Middle East and Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market based on company, product type, end user and key regions.

      This report studies the global market size of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in these regions.
      This research report categorizes the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market by top players/brands, region, type and end user. This report also studies the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Jiangsu Hengrui Medicine Co Ltd
      Jiangsu Nhwa Pharmaceutical Corp Ltd
      Paion AG
      Pfizer Inc
      Primex Pharmaceuticals Oy
      Shire Plc

      Market size by Product
      EL-001
      LASSBio-785
      LASSBio-786
      Midazolam Hydrochloride
      Others
      Market size by End User
      General Anesthetic Effect
      Insomnia
      Hypertension
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now